[Features of hemocomponental therapy in oncological patients].
Sofronov GA, Khanevich MD, Manikhas GM, Lisianskaia AS, Selivanov EA, Feofanova AV, Fadeev RV, Giparovich MA, Pshenkina NN, Dinikin MS.
Sofronov GA, et al.
Vestn Khir Im I I Grek. 2011;170(3):64-8.
Vestn Khir Im I I Grek. 2011.
PMID: 21848242
Russian.